These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27065713)

  • 1. Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases.
    Mehta SS; Gelli M; Agarwal D; Goéré D
    Indian J Surg Oncol; 2016 Jun; 7(2):225-9. PubMed ID: 27065713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details.
    Topgül K; Çetinkaya MB; Çiğdem Arslan N; Gül MK; Çan M; Gürsel MF; Erdem D; Malazgirt Z
    Ulus Cerrahi Derg; 2015; 31(3):138-47. PubMed ID: 26504417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
    Vaira M; Robella M; Mellano A; Sottile A; De Simone M
    Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience.
    Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2013 Dec; 68(6):569-77. PubMed ID: 24193289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study.
    Paasch C; De Santo G; Gamal-Eldin HN; Hünerbein M
    Ann Med Surg (Lond); 2021 Oct; 70():102824. PubMed ID: 34584682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.
    Spiliotis J; Halkia E; de Bree E
    Curr Oncol; 2016 Jun; 23(3):e266-75. PubMed ID: 27330364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
    Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
    J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
    Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Boot H; van Leerdam ME; Hauptmann M; Aalbers AG; Verwaal VJ
    Ann Oncol; 2014 Apr; 25(4):864-869. PubMed ID: 24667719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Iversen LH; Rasmussen PC; Laurberg S
    Br J Surg; 2013 Jan; 100(2):285-92. PubMed ID: 23124619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
    van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW
    JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis.
    Cardi M; Sammartino P; Mingarelli V; Sibio S; Accarpio F; Biacchi D; Musio D; Sollazzo B; Di Giorgio A
    World J Surg Oncol; 2015 Oct; 13():305. PubMed ID: 26493405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    Lee L; Alie-Cusson F; Dubé P; Sideris L
    J Surg Oncol; 2017 Aug; 116(2):236-243. PubMed ID: 28409831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies.
    Li Y; Zhou YF; Liang H; Wang HQ; Hao JH; Zhu ZG; Wan DS; Qin LX; Cui SZ; Ji JF; Xu HM; Wei SZ; Xu HB; Suo T; Yang SJ; Xie CH; Yang XJ; Yang GL
    World J Gastroenterol; 2016 Aug; 22(30):6906-16. PubMed ID: 27570426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion.
    Nassour I; Polanco PM
    Curr Colorectal Cancer Rep; 2017 Apr; 13(2):144-153. PubMed ID: 28890671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.
    Huang CQ; Min Y; Wang SY; Yang XJ; Liu Y; Xiong B; Yonemura Y; Li Y
    Oncotarget; 2017 Aug; 8(33):55657-55683. PubMed ID: 28903452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre.
    Tan G; Chia C; Kumar M; Choo SP; Chia J; Tham CK; Chua C; Soo KC; Teo M
    Int J Hyperthermia; 2017 May; 33(3):288-294. PubMed ID: 27855557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.